News

Foamix news releases

Stay up-to-date on the latest news and innovation from Foamix

Foamix Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Foamix Announces Enrollment of First Patient in Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam

Foamix Announces Issuance of New U.S. Patent Covering A Method of Treating Acne that Expires in 2037

Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea

Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed